×

Cellular therapy

Miltenyi Biotec Inc

http://www.miltenyibiotec.com

Miltenyi Biotec GmbH is a diversified biotechnology company focused on cell separation, molecular biology, GMP manufacturing and cellular therapies. By combining competencies in biologics and device technologies, Miltenyi Biotec is uniquely positioned to provide researchers and clinicians with a wide range of advanced solutions for cellular research, cell therapies and blood/plasma treatments.

  • 12/8/2013
  • 22
  • 0

Opexa Therapeutics , Inc.

http://www.opexatherapeutics.com

Opexa Therapeutics, Inc. (Opexa or Opexa Therapeutics) is a biopharmaceutical company developing autologous cellular therapies to treat several illnesses, including multiple sclerosis (MS), rheumatoid arthritis (RA), and diabetes. These therapies are based on the Company’s T-cell and adult stem cell technologies. Opexa Therapeutics’ lead product, Tovaxin, is a T-cell based therapeutic vaccine for MS. Tovaxin is in a Phase IIb clinical trial. Initial Phase I/II open-label human trials show that T-cell vaccination (TCV) appears to safely induce immune responses that deplete and regulate MRTCs. The Company holds worldwide license for the intellectual property rights and research results of an autologous T-cell vaccine for RA from the Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences of the People's Republic of China. Opexa’s RA T-cell vaccination (TCV) technology allows the isolation of these pathogenic T-cells from synovial fluid drawn from a patient. (Source: 10-K)

  • 12/8/2013
  • 15
  • 0

BrainStorm Cell Therapeutics Inc.

http://www.brainstorm-cell.com

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and Spinal Cord Injury. The adult stem cells are used to create healthy new brain-like cells that replace or support the diseased cells. Patients treated with the Company's NurOwn therapeutic cells are expected to enjoy a rapid recovery and much enhanced quality of life. BrainStorm's therapy has the potential to cure underlying pathology, rather than simply treat symptoms. BrainStorm's management and scientific teams are passionately devoted to the Company's mission: regenerating the mind ... in their lifetime.

  • 12/8/2013
  • 14
  • 0

Biomira Inc.

http://www.biomira.com

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.

  • 12/8/2013
  • 14
  • 0

Note

Not found any data